Angela M Bengtson1, Tamsin K Phillips2, Stanzi M le Roux3, Kirsty Brittain2, Allison Zerbe4, Hlengiwe P Madlala3, Thokozile R Malaba2, Gregory Petro5, Elaine J Abrams6, Landon Myer2. 1. Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA. Electronic address: angela_bengtson@brown.edu. 2. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. 3. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 4. ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, USA. 5. Department of Obstetrics & Gynaecology, University of Cape Town and New Somerset Hospital, Cape Town, South Africa. 6. ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, United States.
Abstract
OBJECTIVE: To examine associations between high blood pressure (BP) when entering antenatal care (ANC) and birth outcomes in a cohort of pregnant HIV- and women living with HIV (WLHIV) initiating antiretroviral treatment (ART). STUDY DESIGN: Prospective cohort study. MAIN OUTCOME MEASURES: Cesarean delivery, preterm birth (<37 weeks' gestation), low birthweight (LBW, <2500 g), small-for-gestational age (SGA, <10th percentile), and large-for-gestational age (LGA, >10th percentile for GA). RESULTS: Of 1116 women (median GA 20 weeks; WLHIV 53%), 48% (53% WLHIV; 43% HIV-) entered ANC with high BP, defined as elevated (120-129 or < 80 mmHg), stage 1 (>130-139 or 80-89) or stage 2 hypertension (≥140 / or ≥ 90). WLHIV were more likely to have high BP (RR 1.32; 95%CI 1.12-1.57), controlling for pre-pregnancy body mass index and additional confounders. In multivariable analysis, there was no evidence that high BP increased the risk of cesarean delivery (RR 1.10, 95% CI 0.92-1.30), preterm birth (RR 1.15, 95% CI 0.81-1.62), LBW (RR 1.16, 95% CI 0.84-1.60) or SGA (RR 1.02, 0.72-1.44), overall or when stratified by HIV-status. High BP was associated with an increased risk of LGA (RR 1.43; 95% CI 1.00-2.03). CONCLUSION: In this setting, half of women had high BP at entry into ANC, with WLHIV at increased risk of high BP. There was no strong evidence that high BP increased the risk of adverse birth outcomes overall, or by HIV-status, with the exception of LGA. WLHIV may be at high risk of high BP during pregnancy and should be monitored closely.
OBJECTIVE: To examine associations between high blood pressure (BP) when entering antenatal care (ANC) and birth outcomes in a cohort of pregnant HIV- and women living with HIV (WLHIV) initiating antiretroviral treatment (ART). STUDY DESIGN: Prospective cohort study. MAIN OUTCOME MEASURES: Cesarean delivery, preterm birth (<37 weeks' gestation), low birthweight (LBW, <2500 g), small-for-gestational age (SGA, <10th percentile), and large-for-gestational age (LGA, >10th percentile for GA). RESULTS: Of 1116 women (median GA 20 weeks; WLHIV 53%), 48% (53% WLHIV; 43% HIV-) entered ANC with high BP, defined as elevated (120-129 or < 80 mmHg), stage 1 (>130-139 or 80-89) or stage 2 hypertension (≥140 / or ≥ 90). WLHIV were more likely to have high BP (RR 1.32; 95%CI 1.12-1.57), controlling for pre-pregnancy body mass index and additional confounders. In multivariable analysis, there was no evidence that high BP increased the risk of cesarean delivery (RR 1.10, 95% CI 0.92-1.30), preterm birth (RR 1.15, 95% CI 0.81-1.62), LBW (RR 1.16, 95% CI 0.84-1.60) or SGA (RR 1.02, 0.72-1.44), overall or when stratified by HIV-status. High BP was associated with an increased risk of LGA (RR 1.43; 95% CI 1.00-2.03). CONCLUSION: In this setting, half of women had high BP at entry into ANC, with WLHIV at increased risk of high BP. There was no strong evidence that high BP increased the risk of adverse birth outcomes overall, or by HIV-status, with the exception of LGA. WLHIV may be at high risk of high BP during pregnancy and should be monitored closely.
Authors: Deborah B Ehrenthal; Claudine Jurkovitz; Matthew Hoffman; Xiaozhang Jiang; William S Weintraub Journal: J Womens Health (Larchmt) Date: 2010-12-31 Impact factor: 2.681
Authors: Joyce L Browne; Verena J M M Schrier; Diederick E Grobbee; Sanne A E Peters; Kerstin Klipstein-Grobusch Journal: J Acquir Immune Defic Syndr Date: 2015-09-01 Impact factor: 3.731
Authors: Marie C D Stoner; Bellington Vwalika; Marcela C Smid; Shalin George; Benjamin H Chi; Elizabeth M Stringer; Jeffrey S A Stringer Journal: Int J Gynaecol Obstet Date: 2016-05-25 Impact factor: 3.561
Authors: Susan Y Chu; William M Callaghan; Shin Y Kim; Christopher H Schmid; Joseph Lau; Lucinda J England; Patricia M Dietz Journal: Diabetes Care Date: 2007-04-06 Impact factor: 19.112
Authors: Landon Myer; Tamsin K Phillips; Allison Zerbe; Kirsty Brittain; Maia Lesosky; Nei-Yuan Hsiao; Robert H Remien; Claude A Mellins; James A McIntyre; Elaine J Abrams Journal: PLoS Med Date: 2018-03-30 Impact factor: 11.069
Authors: Susana Santos; Iris Eekhout; Ellis Voerman; Romy Gaillard; Henrique Barros; Marie-Aline Charles; Leda Chatzi; Cécile Chevrier; George P Chrousos; Eva Corpeleijn; Nathalie Costet; Sarah Crozier; Myriam Doyon; Merete Eggesbø; Maria Pia Fantini; Sara Farchi; Francesco Forastiere; Luigi Gagliardi; Vagelis Georgiu; Keith M Godfrey; Davide Gori; Veit Grote; Wojciech Hanke; Irva Hertz-Picciotto; Barbara Heude; Marie-France Hivert; Daniel Hryhorczuk; Rae-Chi Huang; Hazel Inskip; Todd A Jusko; Anne M Karvonen; Berthold Koletzko; Leanne K Küpers; Hanna Lagström; Debbie A Lawlor; Irina Lehmann; Maria-Jose Lopez-Espinosa; Per Magnus; Renata Majewska; Johanna Mäkelä; Yannis Manios; Sheila W McDonald; Monique Mommers; Camilla S Morgen; George Moschonis; Ľubica Murínová; John Newnham; Ellen A Nohr; Anne-Marie Nybo Andersen; Emily Oken; Adriëtte J J M Oostvogels; Agnieszka Pac; Eleni Papadopoulou; Juha Pekkanen; Costanza Pizzi; Kinga Polanska; Daniela Porta; Lorenzo Richiardi; Sheryl L Rifas-Shiman; Nel Roeleveld; Loreto Santa-Marina; Ana C Santos; Henriette A Smit; Thorkild I A Sørensen; Marie Standl; Maggie Stanislawski; Camilla Stoltenberg; Elisabeth Thiering; Carel Thijs; Maties Torrent; Suzanne C Tough; Tomas Trnovec; Marleen M H J van Gelder; Lenie van Rossem; Andrea von Berg; Martine Vrijheid; Tanja G M Vrijkotte; Oleksandr Zvinchuk; Stef van Buuren; Vincent W V Jaddoe Journal: BMC Med Date: 2018-11-05 Impact factor: 11.150